ALIMS Approves The Sale Of 295 New Medicines
News: The Medicines and Medical Devices Agency of Serbia (ALIMS) has granted approval to the sale of 295 new medicines in Serbia, reports b92.net. Of these 295 newly approved medicines, nine medicines are for the treatment of rare diseases. ALIMS granted approval to the sale of these medicines in 2013, according to ALIMS spokesperson Alexander Tucovic. The agency had also discussed the issue of registering 313 new medicines in the country, of which the registration of 39 medicines has been approved, Tucovic added.